Case Series Summary: In this report, we provide detailed clinical, laboratory, electrocardiographic and echocardiographic descriptions of two -positive cats diagnosed with transient myocardial thickening (TMT) and acute myocardial injury (MI). In both cases, aetiological diagnosis was based on the antibody screening test (all cats had IgM titres ⩾1:64) and MI was demonstrated by a concomitant severe increase of the serum concentration of cardiac troponin I (5.1-23.6 ng/ml; upper hospital limit <0.2 ng/ml). In both cats, TMT and MI were aggravated by left atrial dilation and dysfunction, as well as congestive heart failure. In one cat, atrial standstill was also documented, while the other cat showed an intracardiac thrombus. Both cats underwent an extensive diagnostic work-up aimed at excluding additional comorbidities that could contribute to able to contribute to TMT and MI, and received appropriate antiprotozoal (ie, clindamycin) and cardiovascular therapy (eg, furosemide, pimobendan and clopidogrel). This was followed by a simultaneous decline in serology titres, normalisation of troponin level and the resolution of clinical, electrocardiographic, radiographic and echocardiographic abnormalities. In the light of these results, therapies were interrupted and subsequent controls ruled out any disease relapse.

Relevance And Novel Information: Although represents an often-cited cause of myocarditis in feline medicine, the existing literature on the demonstration of -associated cardiac compromise in cats is extremely limited. Accordingly, this report provides a useful contribution to pertinent scientific literature since it describes TMT and acute MI in two -positive cats.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629561PMC
http://dx.doi.org/10.1177/20551169221131266DOI Listing

Publication Analysis

Top Keywords

transient myocardial
8
myocardial thickening
8
acute myocardial
8
myocardial injury
8
-positive cats
8
thickening associated
4
associated acute
4
injury congestive
4
congestive heart
4
heart failure
4

Similar Publications

Background: Stroke is an important contributor to disability and death globally. Hypertension is a main risk factor for recurrent stroke in patients with ischemic and hemorrhagic stroke or transient ischemic attack. Higher systolic blood pressure, diastolic blood pressure, pulse pressure and mean arterial pressure at admission are independently associated with the risk of stroke recurrence.

View Article and Find Full Text PDF

Fibrotic cardiomyopathy represents a significant pathological condition characterized by the interaction between cardiomyocytes and fibroblasts in the heart, and it currently lacks an effective cure. In vitro platforms, such as engineered heart tissue (EHT) developed through the co-culturing of cardiomyocytes and fibroblasts, are under investigation to elucidate and manipulate these cellular interactions. We present the first integration of mathematical electrophysiological models that encapsulate fibroblast-cardiomyocyte interactions with experimental EHT studies to identify and modulate the ion channels governing these dynamics.

View Article and Find Full Text PDF

: The risks of blood clot formation, stroke, heart failure (HF), and cardiovascular death are enhanced in individuals with atrial flutter (AFL). However, it remains unclear whether left atrial appendage thrombus (LAAT) in individuals with AFL with anticoagulation enhances the risk of cardiovascular morbidity and mortality. Thus, in the current trial, we aimed to evaluate the predictive role of LAAT for cardiovascular outcomes in individuals with AFL who were receiving anticoagulation and admitted for electrical cardioversion.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on developing an AI model to predict myocarditis and cardiovascular issues in cancer patients undergoing immune checkpoint inhibitor therapy, which can improve cancer prognosis but poses cardiovascular risks.
  • The researchers reviewed data from 2,258 patients treated between 2011 and 2022, finding that 11.7% experienced serious cardiovascular events related to the therapy.
  • The AI model, combining electrocardiogram (ECG) data and patient characteristics, showed strong predictive performance with a 0.72 area under the curve, suggesting it could help identify at-risk patients for better clinical management.
View Article and Find Full Text PDF

Background: Tyrosine kinase inhibitors (TKIs) improve prognosis in chronic myeloid leukemia (CML). Nilotinib and ponatinib, second- and third-generation TKIs, respectively, have been reported to cause adverse vascular occlusive events such as myocardial infarction and peripheral arterial disease. However, little is known about the risk of cerebral infarction associated with severe cerebrovascular stenosis, which is a late complication of TKIs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!